COVID-19 and rhino-orbital mucormycosis – A case report
There is a constant rise in cases of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19). Generally, mucormycosis develops in immunosuppression or debilitating diseases. In cases having head and neck involvement, the mold enters the respiratory tract with further involvemen...
Main Authors: | Dilbag Singh, Harveen Kaur, N.C. Kajal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | The Journal of Association of Chest Physicians |
Subjects: | |
Online Access: | http://www.jacpjournal.org/article.asp?issn=2320-8775;year=2023;volume=11;issue=2;spage=100;epage=103;aulast=Singh |
Similar Items
-
SIADH secondary to rhino‐orbito‐cerebral mucormycosis: A case report
by: Bibek Shrestha, et al.
Published: (2024-11-01) -
Rhino-cerebral mucormycosis in patients with COVID-19: clinical cases and treatment in a regional hospital
by: Dovgan E.V., et al.
Published: (2024-03-01) -
Rhino–Orbito–Cerebral Mucormycosis Resistant to Amphotericin B: Two Diabetic Cases
by: Esma Eren, et al.
Published: (2019-09-01) -
Clinical study and outcome of rhino-orbital mucormycosis patients
by: A R Suresha, et al.
Published: (2023-01-01) -
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
by: Ramesh Murthy, et al.
Published: (2022-01-01)